NCT01231009

Brief Summary

Aim of present study is to determine whether corticosteroids and vestibular exercises are equal effective in the recovery of balance in patients with acute vestibular neuritis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jan 2010

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 1, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

November 1, 2010

Status Verified

January 1, 2010

Enrollment Period

2 years

First QC Date

October 29, 2010

Last Update Submit

October 29, 2010

Conditions

Outcome Measures

Primary Outcomes (2)

  • clinical recovery of vestibular function

    clinical examination (nystagmus, Romberg test, head-thrust test, head-shaking test) and questionnaires (Greek edition of Dizziness Handicap Inventory and European Evaluation of Vertigo Scale)

    1 year

  • Laboratory recovery of vestibular

    caloric test and vestibular evoked myogenic potentials

    1 year

Study Arms (2)

Corticosteroids

ACTIVE COMPARATOR

Patients receive for 7 days intravenous corticosteroids, dexamethasone, and they continue receiving for 7 days corticosteroids per os

Drug: CorticosteroidsOther: Vestibular exercises

Vestibular exercises

PLACEBO COMPARATOR

Patients perform for 15 days certain vestibular exercises under suspicion of an expert physiotherapist

Drug: CorticosteroidsOther: Vestibular exercises

Interventions

Intravenous Dexamethasone, 8mg three times per day tapering down for 7 days Per os dexamethasone, 2mg per day tapering down for 7 days

CorticosteroidsVestibular exercises

Vestibular exercises in order to enhance vestibulo-ocular reflex for 15 days under the suspicion of physiotherapist

CorticosteroidsVestibular exercises

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with history of acute or sub-acute rotatory vertigo with postural imbalance, nausea and imbalance.
  • Horizontal-rotatory spontaneous nystagmus.

You may not qualify if:

  • History of vestibular disfunction before the acute onset of symptoms
  • Simultaneous Hearing loss
  • Neurologic disorder
  • Pregnancy or lactation
  • History of psychiatric disorders
  • History of glaucoma
  • Diabetes
  • Hypertension
  • Contraindication in receiving corticosteroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

1st ENT Department, AHEPA University Hospital

Thessaloniki, 54636, Greece

RECRUITING

Related Publications (1)

  • Goudakos JK, Markou KD, Psillas G, Vital V, Tsaligopoulos M. Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014 May;140(5):434-40. doi: 10.1001/jamaoto.2014.48.

MeSH Terms

Conditions

Vestibular Neuronitis

Interventions

Adrenal Cortex Hormones

Condition Hierarchy (Ancestors)

Vestibulocochlear Nerve DiseasesRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone Antagonists

Central Study Contacts

John Goudakos, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 29, 2010

First Posted

November 1, 2010

Study Start

January 1, 2010

Primary Completion

January 1, 2012

Study Completion

January 1, 2013

Last Updated

November 1, 2010

Record last verified: 2010-01

Locations